TAL1 and acute lymphoblastic leukemia: STIL::TAL1 is rare in adult T-ALL patients [14], but those with STIL::TAL1 experience similar 4-year OS rates as those without STIL::TAL1 (both 45%) [116] suggesting outcomes are similar with current treatment regimens.